Personalized Gene-Edited Immune Cell Therapy for Patients with Solid Cancers: Verifying Patient-Specific Cancer Mutation Targets

Personalized Gene-Edited Immune Cell Therapy for Patients with Solid Cancers: Verifying Patient-Specific Cancer Mutation Targets

Background: Precision Cancer Therapies PACT Pharma, a leader in the fields of cancer immunology and cell therapy in collaboration with a UCLA team, presented new data demonstrating for the first time the ability to identify mutation targets unique to each patient’s...

Pin It on Pinterest